227 related articles for article (PubMed ID: 17525887)
21. Thromboembolic risk in hematological malignancies.
Franchini M
Clin Chem Lab Med; 2015 Jul; 53(8):1139-47. PubMed ID: 25503466
[TBL] [Abstract][Full Text] [Related]
22. Thromboembolic complications following aminocaproic acid use in patients with hematologic malignancies.
Juhl RC; Roddy JVF; Wang TF; Li J; Elefritz JL
Leuk Lymphoma; 2018 Oct; 59(10):2377-2382. PubMed ID: 29424601
[TBL] [Abstract][Full Text] [Related]
23. Management of thromboembolism in hematologic malignancies.
Chong BH; Lee SH
Semin Thromb Hemost; 2007 Jun; 33(4):435-48. PubMed ID: 17525901
[TBL] [Abstract][Full Text] [Related]
24. The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies.
Shaw JL; Nielson CM; Park JK; Marongiu A; Soff GA
Eur J Haematol; 2021 May; 106(5):662-672. PubMed ID: 33544940
[TBL] [Abstract][Full Text] [Related]
25. The observation of bleeding complications in haemato-oncological patients: stringent watching, relevant reporting.
Ypma PF; Kerkhoffs JL; van Hilten JA; Middelburg RA; Coccoris M; Zwaginga JJ; Beckers EM; Fijnheer R; van der Meer PF; Brand A
Transfus Med; 2012 Dec; 22(6):426-31. PubMed ID: 23036067
[TBL] [Abstract][Full Text] [Related]
26. Thromboembolic and bleeding complications in acute leukemia.
Kwaan HC; Huyck T
Expert Rev Hematol; 2010 Dec; 3(6):719-30. PubMed ID: 21091148
[TBL] [Abstract][Full Text] [Related]
27. Report of three cases of circulating heparin-like anticoagulants.
Llamas P; Outeiriño J; Espinoza J; Santos AB; Román A; Tomás JF
Am J Hematol; 2001 Aug; 67(4):256-8. PubMed ID: 11443639
[TBL] [Abstract][Full Text] [Related]
28. [Acute thrombotic and hemorragic complications in cancer].
Zini JM
Rev Prat; 2003 Dec; 53(19):2153-9. PubMed ID: 15008472
[TBL] [Abstract][Full Text] [Related]
29. Bleeding frequency and characteristics among hematologic malignancy inpatient rehabilitation patients with severe thrombocytopenia.
Fu JB; Tennison JM; Rutzen-Lopez IM; Silver JK; Morishita S; Dibaj SS; Bruera E
Support Care Cancer; 2018 Sep; 26(9):3135-3141. PubMed ID: 29594490
[TBL] [Abstract][Full Text] [Related]
30. Thrombosis in hematological malignancies: mechanisms and implications.
Horowitz NA; Brenner B
Thromb Res; 2020 Jul; 191 Suppl 1():S58-S62. PubMed ID: 32736780
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology and pathogenesis of incident pain-related disability in malignant hematology: an Italian survey.
Tendas A; Niscola P; Giovannini M; Scaramucci L; Cupelli L; Dentamaro T; de Fabritiis P
Ann Hematol; 2011 Jun; 90(6):719-20. PubMed ID: 20827476
[No Abstract] [Full Text] [Related]
32. Pathogenesis and management of bleeding and thrombosis in plasma cell dyscrasias.
Eby C
Br J Haematol; 2009 Apr; 145(2):151-63. PubMed ID: 19210509
[TBL] [Abstract][Full Text] [Related]
33. Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model.
Sud R; Khorana AA
Thromb Res; 2009; 123 Suppl 4():S18-21. PubMed ID: 19303497
[TBL] [Abstract][Full Text] [Related]
34. Acute appendicitis in adult neutropenic patients with hematologic malignancies.
Forghieri F; Luppi M; Narni F; Morselli M; Potenza L; Bresciani P; Volzone F; Rossi G; Rossi A; Trenti L; Barozzi P; Torelli G
Bone Marrow Transplant; 2008 Nov; 42(10):701-3. PubMed ID: 18679367
[No Abstract] [Full Text] [Related]
35. [Clinical and cytogenetic features of hematologic malignancies associated with acquired trisomy 21].
Wang H; Ni W; Chen Z; Lou J; Xu H; Yu Y; Qian W; Jin J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):576-8. PubMed ID: 18841576
[TBL] [Abstract][Full Text] [Related]
36. Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients.
Samaras P; Dold S; Braun J; Kestenholz P; Breitenstein S; Imhof A; Renner C; Stenner-Liewen F; Pestalozzi BC
Oncology; 2008; 74(3-4):237-44. PubMed ID: 18716418
[TBL] [Abstract][Full Text] [Related]
37. [Approach to special issues associated with myeloproliferative neoplasms].
Kameda T; Shide K; Kubuki Y
Rinsho Ketsueki; 2015 Aug; 56(8):972-80. PubMed ID: 26345555
[TBL] [Abstract][Full Text] [Related]
38. Green tea consumption and hematologic malignancies in Japan: the Ohsaki study.
Naganuma T; Kuriyama S; Kakizaki M; Sone T; Nakaya N; Ohmori-Matsuda K; Hozawa A; Nishino Y; Tsuji I
Am J Epidemiol; 2009 Sep; 170(6):730-8. PubMed ID: 19640889
[TBL] [Abstract][Full Text] [Related]
39. Heparin-induced thrombocytopenia in intensive care patients.
Selleng K; Selleng S; Greinacher A
Semin Thromb Hemost; 2008 Jul; 34(5):425-38. PubMed ID: 18956282
[TBL] [Abstract][Full Text] [Related]
40. Bleeding and thrombosis in myeloproliferative disorders: mechanisms and treatment.
Landolfi R; Rocca B; Patrono C
Crit Rev Oncol Hematol; 1995 Oct; 20(3):203-22. PubMed ID: 8748010
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
